AML-143 Trial in Progress: Phase Ib/II Study of Siremadlin in Combination With Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy (IC)

AML-143 Trial in Progress: Phase Ib/II Study of Siremadlin in Combination With Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy (IC)

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia Vol. 22; p. S217
Main Authors: Daver, Naval G., Wei, Andrew H., Stein, Eytan M., DeAngelo, Daniel J., Pathak, Dhrubajyoti, Xu, Yunnan, Grzesiak, Stephanie, Venditti, Adriano
Format: Journal Article
Language:English
Published: 01-10-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2152-2650
DOI:10.1016/S2152-2650(22)01228-9